The two parties aim to use digital health technology to help people with chronic pain decrease their use of pain medication.
The funds will be used to support the company's rapid growth and brings its personalized medication management platform to other places.
The interactions feature also includes disclosures when medications have other lifestyle implications, such as interactions with specific foods or alcohol.
The company's SaaS offering will adapt to each user's needs, helping them change their behavior, follow doctor's orders more closely, and build healthier habits.
The two companies aim to track adherence to medication protocols for patients with a Substance Use Disorder diagnosis.
The new company will focus on three areas of importance to pharmacy: Digital Solutions, Communication Solutions, and Adherence & Clinical Solutions.
The founders of both companies have a shared vision to enhance the consumer experience for drug pricing and medications.
CoverMyMeds' electronic prior authorization (ePA) service automates and accelerates the prescription approval process.
The new information highlights the reasons why patients use specific prescription drugs and how effective they think they are...
Globally, revenue loss has increased from $564 billion in 2012 to $637 billion in 2015, with US-based revenue losses increasing from $188 billion in 2012 to $250 billion in 2015.